Zhitong Finance App News, Fosun Pharmaceutical (02196.HK) issued an announcement. In order to continue to expand the channels for cultivating and incubating early innovation projects in the pharmaceutical field, the 26th meeting of the 10th board of directors of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (hereinafter referred to as “the Company”) approved the holding subsidiary/enterprise as LPs to participate in the establishment of target funds (composed of two parallel funds set up in Tianjin and Hangzhou respectively) on March 31, 2026.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.